JUNO THERAPEUTICS COM USD0.0001


Updates from The Motley Fool

Latest updates on Juno Therapeutics from Fool.com.  The Fool has written over 100 articles on Juno Therapeutics.
2016's Worst Clinical Failures

It's been a rough year for drugmakers, but late clinical-stage failures made it especially tough ...

The Unsung Heroes of CAR-T

Investors are well aware of the big names in CAR-T therapies, but these companies are working beh...



Stock Performance

View Interactive JUNO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Juno Therapeutics.
Current Price: $20.49
Prev Close: $20.85
Open: $20.66
Bid: $20.51
Ask: $20.53
Day's Range: $19.75 - $20.80
52wk Range: $17.52 - $49.72
Volume: 925,555
Avg Vol 1,853,670
Market Cap: $2B
P/E (ttm): -8.62
EPS (ttm): ($2.42)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Juno Therapeutics.
CAPS Rating 5 out of 5
 
158 Outperform
3 Underperform
CAPS All Stars
 
39 Outperform
1 Underperform

How do you think Juno Therapeutics will perform against the market?



You pick for Juno Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Hans Bishop, CEO

100% Approve

Based on 7 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Juno Therapeutics.

JUNO THERAPEUTICS COM USD0.0001

  • Exchange: NASDAQ